Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical

Abstract

An object of the present invention is to develop a method of enhancing the cognitive ability of a brain to fundamentally cure a disease. It has been found out that, by using a medicament for treating or preventing a disease including a combination of a major tranquilizer, and vitamin C or a salt thereof and, if necessary, drip infusion, an antidepressant and an iron agent, the cognitive ability of a brain is enhanced, thus, an arbitrary disease including various cancers can be treated. The present invention also provides a method for treating or preventing a disease including a step of administering a major tranquilizer, and vitamin C or a salt thereof to a subject suffering from the disease.

1 . A method for treating or preventing cancer, comprising administering to a patient in need thereof an effective amount of haloperidol, vitamin C or a salt thereof, fluvoxamine maleate, and sodium ferrous citrate, wherein:
 the haloperidol is administered at a daily dose of 0.25 mg to 1 mg;   the vitamin C is administered at a daily dose of 600 mg to 1800 mg; and   the fluovoxamine maleate is administered when blood potassium is decreased.   
     
     
         2 - 6 . (canceled) 
     
     
         7 . The method according to  claim 1 , wherein the vitamin C is ascorbic acid which is an artificial substance. 
     
     
         8 . (canceled) 
     
     
         9 . The method according to  claim 1 , further combined with drip infusion. 
     
     
         10 . The method according to  claim 1 , wherein the drip infusion is a physiological buffer containing maltose. 
     
     
         11 - 17 . (canceled) 
     
     
         18 . The method according to  claim 9 , wherein the drip infusion is administered until appetite is worked up. 
     
     
         19 . The method according to  claim 1 , wherein the haloperidol is administered before bedtime. 
     
     
         20 - 22 . (canceled) 
     
     
         23 . The method according to  claim 1 , wherein the vitamin C is further combined with pantothenic acid or a salt thereof. 
     
     
         24 - 25 . (canceled) 
     
     
         26 . The method medicament-according to  claim 1 , wherein the cancer is selected from large intestine cancer, colon cancer, rectum cancer, thyroid cancer, esophagus cancer, chorionic cancer, gallbladder cancer, neuroblastoma, maxillary cancer, oral cavity cancer, genitourinary cancer, malignant lymphoma, liver cancer, prostate cancer, lung cancer, lung cell cancer, breast cancer, stomach cancer, bladder cancer, pancreas cancer, testis cancer, uterus cancer, corpus uteri cancer, cervix uteri cancer, ovary cancer, pharynx cancer, myelocytic leukemia, brain tumor, biliary cancer, neuroblasto tumor, melanocytoma, gastrinoma, insulinoma, carcinoid, kidney cancer, testicular cancer, adult T cell leukemia, vagina cancer, vulva cancer, skin cancer, upper airway cancer, head and neck cancer, teratoma, gallbladder cancer, acute myelocytic leukemia, acute lymphatic leukemia, malignant lymphoma, sarcoma, malignant melanoma, lymphoma, lung squamous epithelium cancer and spinocerebellar degeneration. 
     
     
         27 - 30 . (canceled) 
     
     
         31 . Use of a combination of haloperidol, vitamin C or a salt thereof, fluvoxamine maleate, and sodium ferrous citrate, in the manufacture of a medicament for treating or preventing cancer, wherein:
 the haloperidol is administered at a daily dose of 0.25 mg to 1 mg;   the vitamin C is contained so that it is administered at a daily dose of 600 mg to 1800 mg as an effective amount; and   the fluovoxamine maleate is administered when blood potassium is decreased.   
     
     
         32 . The use according to  claim 31 , wherein the combination further comprises a drip infusion. 
     
     
         33 - 38 . (canceled) 
     
     
         39 . The method according to  claim 1 , wherein the fluovoxamine maleate is administered at an amount of 25 mg or 50 mg.